The Potential of CAR T Cell Therapy in Pancreatic Cancer

Pancreatic cancer has a dismal prognosis and effective treatment options are limited. It is projected to be the second most common cause of cancer related mortality in the United States by 2030 and there is urgent unmet need for novel systemic treatment options. Immunotherapy with antibodies targeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Akce, Mehmet, Zaidi, Mohammad Y., Waller, Edmund K., El-Rayes, Bassel F., Lesinski, Gregory B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167429/
https://www.ncbi.nlm.nih.gov/pubmed/30319627
http://dx.doi.org/10.3389/fimmu.2018.02166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167429/
https://www.ncbi.nlm.nih.gov/pubmed/30319627
http://dx.doi.org/10.3389/fimmu.2018.02166

Ejemplares similares